Free Trial
OTCMKTS:EVIO

EVIO (EVIO) Stock Price, News & Analysis

EVIO logo

About EVIO Stock (OTCMKTS:EVIO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
400,001 shs
Average Volume
1.42 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

EVIO, Inc. provides analytical testing and consulting services for cannabis and hemp industry. The company was founded in 2014 and is based in Henderson, Nevada.

Receive EVIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EVIO and its competitors with MarketBeat's FREE daily newsletter.

EVIO Stock News Headlines

Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
See More Headlines

EVIO Stock Analysis - Frequently Asked Questions

Shares of EVIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that EVIO investors own include Organigram (OGI), Unrivaled Brands (TRTC), Aurora Cannabis (ACB), SinglePoint (SING), Aethlon Medical (AEMD), 22nd Century Group (XXII) and Invictus MD Strategies (IVITF).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:EVIO
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:EVIO) was last updated on 5/12/2025 by MarketBeat.com Staff
From Our Partners